AOP Orphan completes enrollment in phase III trial of ropeginterferon alfa 2b March 9, 2015 No Comments
Boehringer Ingelheim files for approval of dabigatran antidote idarucizumab March 3, 2015 No Comments
Biogen Idec and Sobi report topline data from phase III Alprolix pediatric trial March 3, 2015 No Comments
Isis Pharmaceuticals announces phase I results for prekallikrein inhibitor for HAE Feb. 25, 2015 No Comments